Find clinical trials for Lymphoma in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Phoenix, AZ, USA:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 88 other locations
(R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. However, single drug therapies have limitations, therefore, the current...
Phase 2
Phoenix, Arizona, United States and 7 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Gilbert, Arizona, United States and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Phoenix, Arizona, United States and 82 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Phoenix, Arizona, United States and 73 other locations
of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...
Phase 1
Gilbert, Arizona, United States and 6 other locations
in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...
Phase 2
Tempe, Arizona, United States and 85 other locations
grade myeloid malignancies, acute lymphocytic leukemia (ALL), R/R lymphoma, and R/R solid tumors. The study will identify the pharmacologica...
Phase 1
Scottsdale, Arizona, United States and 10 other locations
or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...
Phase 1
Phoenix, Arizona, United States and 25 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Phoenix, Arizona, United States and 19 other locations
Clinical trials
Research sites
Resources
Legal